[go: up one dir, main page]

ES8703424A1 - Procedimiento para la obtencion de compuestos de amida - Google Patents

Procedimiento para la obtencion de compuestos de amida

Info

Publication number
ES8703424A1
ES8703424A1 ES550926A ES550926A ES8703424A1 ES 8703424 A1 ES8703424 A1 ES 8703424A1 ES 550926 A ES550926 A ES 550926A ES 550926 A ES550926 A ES 550926A ES 8703424 A1 ES8703424 A1 ES 8703424A1
Authority
ES
Spain
Prior art keywords
rest
lower alkyl
aryl
formula
carbocyclic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES550926A
Other languages
English (en)
Other versions
ES550926A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Publication of ES550926A0 publication Critical patent/ES550926A0/es
Publication of ES8703424A1 publication Critical patent/ES8703424A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

PROCEDIMIENTO PARA LA OBTENCION DE COMPUESTOS DE AMIDA. CONSISTENTE EN: HACER REACCIONAR UN COMPUESTO DE FORMULA (II) CON UN COMPUESTO DE FORMULA (III) SEGUN EL METODO DE CARBODIIMIDA CON N,NK-DICILOHEXIL-CARBODIIMIDA EN PRESENCIA DE 1-HIDROXIBENZOTRIAZOL, PARA OBTENER LOS COMPUESTOS DE FORMULA GENERAL (I). SIENDO: N, 1, 2 O 3; AR, UN RESTO ARILO CARBOCICLICO O HETEROCICLICO; AC, EL RESTO ACILO DE UN ACIDO; Z, UN RESTO -OR7 O -NR8R9; R1, HIDROGENO, ALQUILO INFERIOR INSUSTITUIDO O SUSTITUIDO, UN RESTO ARILO U OTROS; R2 Y R3, INDEPENDIENTEMENTE, HIDROGENO, ALQUILO INFERIOR, FORMILO U OTROS; R4, H O ALQUILO INFERIOR; R5 Y R6, INDEPENDIENTEMENTE, H, ALQUILO INFERIOR, O UN RESTO ARILO CARBOCICLICO O HETEROCICLICO; R7, R8 Y R9, H, ALQUILO O UN RESTO ARILO; RK4, RK5 Y RK6, LOS MISMOS SIGNIFICADOS QUE R4, R5 Y R6 PERO PUEDEN SER DISTINTOS QUE EN LA FORMULA (II); NK ES 0, 1 O 2; NL, 0, 1 O 2; Y RB, UN GRUPO CARBOXI. UTILIZABLES EN EL TRATAMIENTO DE ENFERMEDADES CARDIOVASCULARES.
ES550926A 1983-11-16 1986-01-16 Procedimiento para la obtencion de compuestos de amida Expired ES8703424A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH615483 1983-11-16
CH342584 1984-07-13

Publications (2)

Publication Number Publication Date
ES550926A0 ES550926A0 (es) 1987-02-16
ES8703424A1 true ES8703424A1 (es) 1987-02-16

Family

ID=25692968

Family Applications (4)

Application Number Title Priority Date Filing Date
ES537646A Expired ES8706634A1 (es) 1983-11-16 1984-11-14 Procedimiento para la obtencion de compuestos de amida
ES550927A Expired ES8703427A1 (es) 1983-11-16 1986-01-16 Procedimiento para la obtencion de compuestos de amida
ES550926A Expired ES8703424A1 (es) 1983-11-16 1986-01-16 Procedimiento para la obtencion de compuestos de amida
ES550928A Expired ES8703428A1 (es) 1983-11-16 1986-01-16 Procedimiento para la obtencion de compuestos de amida

Family Applications Before (2)

Application Number Title Priority Date Filing Date
ES537646A Expired ES8706634A1 (es) 1983-11-16 1984-11-14 Procedimiento para la obtencion de compuestos de amida
ES550927A Expired ES8703427A1 (es) 1983-11-16 1986-01-16 Procedimiento para la obtencion de compuestos de amida

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES550928A Expired ES8703428A1 (es) 1983-11-16 1986-01-16 Procedimiento para la obtencion de compuestos de amida

Country Status (13)

Country Link
EP (1) EP0145956A1 (es)
KR (1) KR850003713A (es)
AU (1) AU578633B2 (es)
DD (1) DD228547A5 (es)
DK (1) DK543084A (es)
ES (4) ES8706634A1 (es)
FI (1) FI844466L (es)
GR (1) GR80948B (es)
HU (1) HU193909B (es)
IL (1) IL73509A (es)
NO (1) NO844560L (es)
NZ (1) NZ210223A (es)
PT (1) PT79498B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4994476A (en) * 1984-10-31 1991-02-19 Bristol-Myers Company Dihydropyridin-3,5-dicarboxylates incorporating aryloxypropanolamine moieties
JPH0676405B2 (ja) * 1986-06-13 1994-09-28 日清製粉株式会社 １，４―ジヒドロピリジン誘導体およびそれを含有する医薬組成物
US4808603A (en) * 1985-08-14 1989-02-28 Ciba-Geigy Corporation 3,5-diacyl-2,6-dialkyl-4-aryl-1,4-dihydropyridines, their use, and pharmaceutical compositions thereof
US4771057A (en) * 1986-02-03 1988-09-13 University Of Alberta Reduced pyridyl derivatives with cardiovascular regulating properties
IT1204460B (it) * 1986-02-20 1989-03-01 Glaxo Spa Derivati eterociclici
CA2056799C (en) * 1990-11-30 2002-01-01 Hiroshi Ikawa 1,4-dihydropyridine derivatives and methods of producing the same
EP0536671B1 (de) * 1991-10-07 1996-03-06 Hoechst Aktiengesellschaft Carbonsäureester-Schutzgruppen, ein Verfahren zu ihrer Herstellung, ihre Kopplung an eine funktionelle Gruppe sowie ihre Verwendung
US6265417B1 (en) 1997-12-18 2001-07-24 Abbott Laboratories Potassium channel openers
US6593335B1 (en) * 1997-12-18 2003-07-15 Abbott Laboratories Potassium channel openers
CN107857712B (zh) * 2016-09-22 2022-09-09 烟台益诺依生物医药科技有限公司 (r)-3-甲基-2-(3-氧代酰胺基)正丁酸酯

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4285955A (en) * 1978-10-31 1981-08-25 Bayer Aktiengesellschaft 1,4-Dihydropyridinecarboxylic acids
DE3042769A1 (de) * 1980-11-13 1982-06-09 Bayer Ag, 5090 Leverkusen C-3 verknuepfte 1,4-dihydropyridine, ihre verwendung in arzneimitteln und verfahren zu ihrer herstellung
FR2508446B1 (fr) * 1981-06-25 1986-05-02 Rhone Poulenc Agrochimie Herbicides a fonctions amide et ester derives de la pyridine ainsi que leur procede de preparation et leur application
EP0111453A1 (de) * 1982-12-10 1984-06-20 Ciba-Geigy Ag Amid-Verbindungen
DE3319956A1 (de) * 1983-06-01 1984-12-06 Bayer Ag, 5090 Leverkusen 1,4-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln
US4755512A (en) * 1984-04-11 1988-07-05 Bristol-Myers Company Pharmaceutically useful dihydropyridinyldicarboxylate amides and esters incorporating arylpiperazinylalkyl moities

Also Published As

Publication number Publication date
PT79498B (en) 1987-01-13
ES8703427A1 (es) 1987-02-16
IL73509A (en) 1988-05-31
AU578633B2 (en) 1988-11-03
FI844466A7 (fi) 1985-05-17
DD228547A5 (de) 1985-10-16
FI844466A0 (fi) 1984-11-14
ES550928A0 (es) 1987-02-16
IL73509A0 (en) 1985-02-28
ES550926A0 (es) 1987-02-16
AU3547484A (en) 1985-05-23
GR80948B (en) 1985-03-01
KR850003713A (ko) 1985-06-26
ES537646A0 (es) 1987-06-16
PT79498A (en) 1984-12-01
FI844466L (fi) 1985-05-17
HU193909B (en) 1987-12-28
DK543084A (da) 1985-05-17
EP0145956A1 (de) 1985-06-26
ES8706634A1 (es) 1987-06-16
NO844560L (no) 1985-05-20
NZ210223A (en) 1988-10-28
HUT35645A (en) 1985-07-29
ES8703428A1 (es) 1987-02-16
ES550927A0 (es) 1987-02-16
DK543084D0 (da) 1984-11-15

Similar Documents

Publication Publication Date Title
NO168705C (no) 3-nitro-kinoliner.
ES8706606A1 (es) Un procedimiento para preparar aril-hidroxamatos
ES8404330A1 (es) Un metodo para la produccion de derivados de esteres de acidos 1,4-dihidropiridin-3,5-dicarboxilicos.
AR241474A1 (es) Preparacion de derivados de acido 3-aciltriciclo ¡5.2.1.0(2.6)¿-3-azadecan-4-carboxilico utiles como inhibidores de la enzima convertidora en angiotensina.
ES8303329A1 (es) Procedimiento para la obtencion de acidos 1-carboxi-(azaal- canoil o azaaralcanoil)-indolin-2-carboxilicos.
ES8703424A1 (es) Procedimiento para la obtencion de compuestos de amida
KR850002269A (ko) 피리도인돌 유도체의 제조방법
ES480151A1 (es) Un procedimiento para la obtencion de nuevos azacicloalcanos.
DK182783D0 (da) Fremgangsmade til fremstilling af 1-carboxy-(alkanoyl eller aralkanoyl)-indolin-2-carboxylsyreestere eller salte deraf
ES8307718A1 (es) "procedimiento de preparar amidoaminoacidos y similares".
ES8706151A1 (es) Un procedimiento para preparar un derivado de 1,6-naftiri- din-2(1h)-ona
ES8602798A1 (es) Un procedimiento para la preparacion de nuevos analogos de la mitomicina.
AR013183A1 (es) Procedimiento para producir un compuesto derivado de indol, compuestos obtenidos e intermediarios
ES8603876A1 (es) Derivados de pirazol-piridina
ES8707204A1 (es) Procedimiento para preparar diazepinoindoles
ES2062223T3 (es) Derivados de imidazol, procedimiento para la preparacion de los mismos y agentes antiulcera que los contienen.
ES2061525T3 (es) Indoloquinoxalinas con sustituyentes en la posicion 6 que contienen grupos ciclicos.
KR850001165A (ko) 중추 신경계 활성을 갖는 피롤리디논의 제조방법
ES8504776A1 (es) Un metodo para preparar compuestos de fenilpiperazina sustituidos
ES8609259A1 (es) Procedimiento para la obtencion de lactamas biciclicas.
ES8801906A1 (es) Procedimiento de produccion de derivados as-triazinos condensados
ATE29253T1 (de) Verfahren zur herstellung von 4-chinolinonen.
ES324379A1 (es) Un metodo para la preparacion de derivados basicos de ftalanos e isocromanos.
AR241490A1 (es) Procedimiento para preparar derivados de isoquinolina.
ES8203879A1 (es) Procedimiento para preparar butirolactonas.